When one of the world’s leading pharmaceutical and health-aids
companies needed to leverage and manage, their $1.2 billion spend
on business services and clinical research, iServiceX provided
the strategic insight.
iServiceX designed and implemented the changes required to control
spend, improve R&D effectiveness, and increase return on investment.
The firm has applied its new approach to the categories that comprise
all of business services and has partnered with the Divisions
that have the largest budge impact. Compliance has improved to
a goal of 85% and the participation of Procurement has formulated
a process to get ahead of the statement of work and contracting
process to target a 24% reduction of blended rates for all Vendors.